Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Interventional 18 Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 21 Head and Neck Neoplasms 17 Prostatic Neoplasms 15 Neoplasms 13 Lung Neoplasms 12 Radiation Injuries 9 Esophageal Neoplasms 8 Rectal Neoplasms 7 Glioma 7 Brain Neoplasms 7 Glioblastoma 6 Carcinoma, Non-Small-Cell Lung 6 Uterine Cervical Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 5 Neoplasm Metastasis 5 Carcinoma, Hepatocellular 4 Stomach Neoplasms 3 Colorectal Neoplasms 3 Central Nervous System Neoplasms 3 Astrocytoma 3 Xerostomia 2 Urinary Bladder Neoplasms 2 Small Cell Lung Carcinoma 2 Sarcoma 2 Salivary Gland Neoplasms 2 Pelvic Neoplasms 2 Osteoradionecrosis 2 Lymphedema 2 Kidney Neoplasms 2 Esthesioneuroblastoma, Olfactory 2

Interventions

Sunitinib 17 Sorafenib 16 pazopanib 7 cabozantinib 7 Axitinib 7 Blood Specimen Collection 6 Bevacizumab 6 avelumab 5 Immunohistochemistry 5 temsirolimus 4 pembrolizumab 3 Watchful Waiting 3 Specimen Handling 3 Immunotherapy 3 Gene Expression Profiling 3 Everolimus 3 Urine Specimen Collection 2 Nephrectomy 2 Magnetic Resonance Spectroscopy 2 Magnetic Resonance Imaging 2 Flow Cytometry 2 Data Collection 2 Amplified Fragment Length Polymorphism Analysis 2 trastuzumab deruxtecan 1 lenvatinib 1 fluoroazomycin arabinoside 1 enfortumab vedotin 1 darolutamide 1 atezolizumab 1 aldesleukin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Carcinoma, Renal Cell × Radiotherapy × Clear all

NCT06583070 2026-01-28

COSTAR

Peking University First Hospital

Carcinoma, Renal Cell, Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡